Its Superior technologies not just request to rework procedure paradigms in cancer therapy but will also lengthen to addressing infectious ailments, therefore broadening its opportunity industry impact.With a sturdy medical-stage pipeline, Agenus harnesses a mix of proprietary antibody platforms, which include Retrocyte Screen™ and SECANT®, and